| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, April 2008, p. 1774-1780, Vol. 76, No. 4
0019-9567/08/$08.00+0 doi:10.1128/IAI.01629-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Veterinary and Biomedical Sciences, Pennsylvania State University, 115 Henning Building, University Park, Pennsylvania 16802,1 Graduate Program in Immunology and Infectious Diseases,2 Graduate Program in Pathobiology,3 Center for Biologics Evaluation and Research, FDA, 29 Lincoln Drive, Bethesda, Maryland 208924
Received 7 December 2007/ Returned for modification 8 January 2008/ Accepted 5 February 2008
Bordetella pertussis, a causative agent of whooping cough, expresses BrkA, which confers serum resistance, but the closely related human pathogen that also causes whooping cough, Bordetella parapertussis, does not. Interestingly, B. parapertussis, but not B. pertussis, produces an O antigen, a factor shown in other models to confer serum resistance. Using a murine model of infection, we determined that O antigen contributes to the ability of B. parapertussis to colonize the respiratory tract during the first week of infection, but not thereafter. Interestingly, an O antigen-deficient strain of B. parapertussis was not defective in colonizing mice lacking the complement cascade. O antigen prevented both complement component C3 deposition on the surface and complement-mediated killing of B. parapertussis. In addition, O antigen was required for B. parapertussis to systemically spread in complement-sufficient mice, but not complement-deficient mice. These data indicate that O antigen enables B. parapertussis to efficiently colonize the lower respiratory tract by protecting against complement-mediated control and clearance.
Published ahead of print on 19 February 2008.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|